menu ☰
menu ˟

FDA approves Halaven for metastatic, unresectable liposarcoma

28 Jan 2016
The FDA today approved the chemotherapy drug eribulin mesylate for the treatment of patients with unresectable or metastatic liposarcoma who previously received anthracycline-containing chemotherapy.Liposarcoma is a type of soft tissue sarcoma that o...

Click here to view the full article which appeared in Hematology Oncology

Please note

The news articles accessible on the Health Well website have been compiled from various sources that are not controlled by the Institute of Public Health in Ireland (IPH). IPH is therefore not responsible for the content of external websites and the inclusion of a link to an external website from the Health Well should not be understood to be an endorsement of that website.